Evaluation of new anti-infective drugs for the treatment of acute suppurative arthritis in children

J. D. Nelson, C. Norden, J. T. Mader, G. B. Calandra

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Diagnostic criteria for bacterial suppurative arthritis include the demonstration of an inflammatory exudate by aspiration of synovial fluid and the isolation of bacteria from cultures of synovial fluid and/or blood. Clinical manifestations include joint effusion, swelling, tenderness, and pain, with or without redness of the overlying skin. Management consists of antimicrobial therapy, measures designed to relieve symptoms, surgical drainage of infected fluid, and physical therapy. Studies of new anti- infective therapy should be limited to cases of bacterial origin. Prospective, randomized, double-blind or evaluator-blinded, active-control comparative clinical trials should be performed. Clinical response is characterized as success (cure), failure, or indeterminate outcome. The most common successful microbiological outcome is presumptive eradication. Follow- up should continue for 1 year before the final assessment.

Original languageEnglish (US)
JournalClinical Infectious Diseases
Volume15
Issue numberSUPPL. 1
StatePublished - 1992

Fingerprint

Infectious Arthritis
Synovial Fluid
Fluid Therapy
Exudates and Transudates
Pharmaceutical Preparations
Drainage
Joints
Clinical Trials
Bacteria
Pain
Skin
Therapeutics
Aspirations (Psychology)

ASJC Scopus subject areas

  • Immunology

Cite this

Evaluation of new anti-infective drugs for the treatment of acute suppurative arthritis in children. / Nelson, J. D.; Norden, C.; Mader, J. T.; Calandra, G. B.

In: Clinical Infectious Diseases, Vol. 15, No. SUPPL. 1, 1992.

Research output: Contribution to journalArticle

@article{2aea2fd9123f4c9ebad1d32c694ee235,
title = "Evaluation of new anti-infective drugs for the treatment of acute suppurative arthritis in children",
abstract = "Diagnostic criteria for bacterial suppurative arthritis include the demonstration of an inflammatory exudate by aspiration of synovial fluid and the isolation of bacteria from cultures of synovial fluid and/or blood. Clinical manifestations include joint effusion, swelling, tenderness, and pain, with or without redness of the overlying skin. Management consists of antimicrobial therapy, measures designed to relieve symptoms, surgical drainage of infected fluid, and physical therapy. Studies of new anti- infective therapy should be limited to cases of bacterial origin. Prospective, randomized, double-blind or evaluator-blinded, active-control comparative clinical trials should be performed. Clinical response is characterized as success (cure), failure, or indeterminate outcome. The most common successful microbiological outcome is presumptive eradication. Follow- up should continue for 1 year before the final assessment.",
author = "Nelson, {J. D.} and C. Norden and Mader, {J. T.} and Calandra, {G. B.}",
year = "1992",
language = "English (US)",
volume = "15",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Evaluation of new anti-infective drugs for the treatment of acute suppurative arthritis in children

AU - Nelson, J. D.

AU - Norden, C.

AU - Mader, J. T.

AU - Calandra, G. B.

PY - 1992

Y1 - 1992

N2 - Diagnostic criteria for bacterial suppurative arthritis include the demonstration of an inflammatory exudate by aspiration of synovial fluid and the isolation of bacteria from cultures of synovial fluid and/or blood. Clinical manifestations include joint effusion, swelling, tenderness, and pain, with or without redness of the overlying skin. Management consists of antimicrobial therapy, measures designed to relieve symptoms, surgical drainage of infected fluid, and physical therapy. Studies of new anti- infective therapy should be limited to cases of bacterial origin. Prospective, randomized, double-blind or evaluator-blinded, active-control comparative clinical trials should be performed. Clinical response is characterized as success (cure), failure, or indeterminate outcome. The most common successful microbiological outcome is presumptive eradication. Follow- up should continue for 1 year before the final assessment.

AB - Diagnostic criteria for bacterial suppurative arthritis include the demonstration of an inflammatory exudate by aspiration of synovial fluid and the isolation of bacteria from cultures of synovial fluid and/or blood. Clinical manifestations include joint effusion, swelling, tenderness, and pain, with or without redness of the overlying skin. Management consists of antimicrobial therapy, measures designed to relieve symptoms, surgical drainage of infected fluid, and physical therapy. Studies of new anti- infective therapy should be limited to cases of bacterial origin. Prospective, randomized, double-blind or evaluator-blinded, active-control comparative clinical trials should be performed. Clinical response is characterized as success (cure), failure, or indeterminate outcome. The most common successful microbiological outcome is presumptive eradication. Follow- up should continue for 1 year before the final assessment.

UR - http://www.scopus.com/inward/record.url?scp=0026448492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026448492&partnerID=8YFLogxK

M3 - Article

C2 - 1477226

AN - SCOPUS:0026448492

VL - 15

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - SUPPL. 1

ER -